CAN BUSINESS COLLABORATIONS PUT PATIENTS FIRST?
Yes. In fact, we believe delivering value and satisfaction to patients, their families and caregivers is the
surest path to shared success. We and our parent company have successfully collaborated with dozens of the world’s
leading organizations to:
- Create innovation in neurology, oncology and other disease areas
- Build new business models
- Expand access to medicine worldwide
LEARN ABOUT OTHER TYPES OF EISAI COLLABORATIONS
OUR COLLABORATIONS HAVE SHOWN THAT COMBINED PASSION FOR PATIENTS LEADS TO SUCCESS
Our determination to bring innovations to people who need them most inspired us to develop product-focused collaborations. These strategic relationships have led to billion-dollar-plus products like Aricept® and AcipHex®. Would your business like to be part of that kind of success?
WE’RE INVESTED IN SYNERGISTIC PARTNERING AND SHARED PURPOSE
We’ve even formed a strategic investment organization — Eisai Innovation Inc. (EII) — to identify and nurture synergies between our companies and organizations that are as passionate about patient care as we are. EII invests globally in research collaborations that prioritize disease prevention, prediction and treatment, with the overarching goal of advancing human health care.
LET’S WORK TOGETHER TO CHANGE PATIENTS’ LIVES FOR THE BETTER
Does your pharmaceutical or biotech company share our goal of addressing unmet medical needs and increasing the
benefits of health care? If so, let’s talk soon.